Jazz Pharmaceuticals to Present at Healthcare Conferences
PALO ALTO, Calif., March 11 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Samuel R. Saks, M.D., the company's Chief Executive Officer, will provide a corporate presentation at two upcoming investor conferences.
Dr. Saks will speak at the Cowen and Company 28th Annual Health Care Conference at 4:45 p.m. Eastern Time, Monday, March 17, 2008 in Boston.
On Wednesday, March 19, 2008, Dr. Saks will present at the Lehman Brothers 11th Annual Global Healthcare Conference at 11:15 a.m. Eastern Time in Miami, Fla.
A live webcast of the presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website for two weeks following each presentation.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
SOURCE Jazz Pharmaceuticals, Inc.-0- 03/11/2008
/CONTACT: Jim Karrels, Executive Director, Finance, of Jazz
Pharmaceuticals, Inc., +1-650-496-2800, investorinfo@jazzpharmaceuticals.com/
/Web site: http://www.jazzpharmaceuticals.com /
(JAZZ)